Global Bioengineered Skin Substitutes Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Publisher Name :
Date: 17-May-2022
No. of pages: 123

The Bioengineered Skin Substitutes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Bioengineered Skin Substitutes market size is estimated to be worth US$ 1507.6 million in 2021 and is forecast to a readjusted size of USD 3190.3 million by 2028 with a CAGR of 11.3% during forecast period 2022-2028. Hospitals accounting for % of the Bioengineered Skin Substitutes global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Allogeneic Acellular segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Bioengineered Skin Substitutes include Allergan (AbbVie), AlloSource, Organogenesis, BD, and Smith & Nephew, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Bioengineered Skin Substitutes market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Allogeneic Acellular

- Xenogeneic

- Allogeneic Cells

- Autologous

Market segment by Application, can be divided into

- Hospitals

- Specialty Clinics

- Wound Care Centers

Market segment by players, this report covers

- Allergan (AbbVie)

- AlloSource

- Organogenesis

- BD

- Smith & Nephew

- Integra LifeSciences

- Synthes (Johnson & Johnson)

- Axogen

- Vericel Corporation

- LifeNet Health

- MTF Biologics

- Arthrex

- Wright Medical Group NV (Stryker)

- Cook Biotech Incorporated

- Aroa Biosurgery

- Surgalign Holdings

- Anika Therapeutics

- Forticell Bioscience

- MLM Biologics

- Promethean LifeSciences

Market segment by regions, regional analysis covers

- North America (United States, Canada, and Mexico)

- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

- South America (Brazil, Argentina, Rest of South America)

- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Bioengineered Skin Substitutes product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Bioengineered Skin Substitutes, with revenue, gross margin and global market share of Bioengineered Skin Substitutes from 2019 to 2022.

Chapter 3, the Bioengineered Skin Substitutes competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Bioengineered Skin Substitutes market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Bioengineered Skin Substitutes research findings and conclusion, appendix and data source.

Global Bioengineered Skin Substitutes Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Bioengineered Skin Substitutes
1.2 Classification of Bioengineered Skin Substitutes by Type
1.2.1 Overview: Global Bioengineered Skin Substitutes Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Bioengineered Skin Substitutes Revenue Market Share by Type in 2021
1.2.3 Allogeneic Acellular
1.2.4 Xenogeneic
1.2.5 Allogeneic Cells
1.2.6 Autologous
1.3 Global Bioengineered Skin Substitutes Market by Application
1.3.1 Overview: Global Bioengineered Skin Substitutes Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Wound Care Centers
1.4 Global Bioengineered Skin Substitutes Market Size & Forecast
1.5 Global Bioengineered Skin Substitutes Market Size and Forecast by Region
1.5.1 Global Bioengineered Skin Substitutes Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Bioengineered Skin Substitutes Market Size by Region, (2017-2022)
1.5.3 North America Bioengineered Skin Substitutes Market Size and Prospect (2017-2028)
1.5.4 Europe Bioengineered Skin Substitutes Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Bioengineered Skin Substitutes Market Size and Prospect (2017-2028)
1.5.6 South America Bioengineered Skin Substitutes Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Bioengineered Skin Substitutes Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Bioengineered Skin Substitutes Market Drivers
1.6.2 Bioengineered Skin Substitutes Market Restraints
1.6.3 Bioengineered Skin Substitutes Trends Analysis
2 Company Profiles
2.1 Allergan (AbbVie)
2.1.1 Allergan (AbbVie) Details
2.1.2 Allergan (AbbVie) Major Business
2.1.3 Allergan (AbbVie) Bioengineered Skin Substitutes Product and Solutions
2.1.4 Allergan (AbbVie) Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Allergan (AbbVie) Recent Developments and Future Plans
2.2 AlloSource
2.2.1 AlloSource Details
2.2.2 AlloSource Major Business
2.2.3 AlloSource Bioengineered Skin Substitutes Product and Solutions
2.2.4 AlloSource Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AlloSource Recent Developments and Future Plans
2.3 Organogenesis
2.3.1 Organogenesis Details
2.3.2 Organogenesis Major Business
2.3.3 Organogenesis Bioengineered Skin Substitutes Product and Solutions
2.3.4 Organogenesis Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Organogenesis Recent Developments and Future Plans
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business
2.4.3 BD Bioengineered Skin Substitutes Product and Solutions
2.4.4 BD Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 BD Recent Developments and Future Plans
2.5 Smith & Nephew
2.5.1 Smith & Nephew Details
2.5.2 Smith & Nephew Major Business
2.5.3 Smith & Nephew Bioengineered Skin Substitutes Product and Solutions
2.5.4 Smith & Nephew Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Smith & Nephew Recent Developments and Future Plans
2.6 Integra LifeSciences
2.6.1 Integra LifeSciences Details
2.6.2 Integra LifeSciences Major Business
2.6.3 Integra LifeSciences Bioengineered Skin Substitutes Product and Solutions
2.6.4 Integra LifeSciences Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Integra LifeSciences Recent Developments and Future Plans
2.7 Synthes (Johnson & Johnson)
2.7.1 Synthes (Johnson & Johnson) Details
2.7.2 Synthes (Johnson & Johnson) Major Business
2.7.3 Synthes (Johnson & Johnson) Bioengineered Skin Substitutes Product and Solutions
2.7.4 Synthes (Johnson & Johnson) Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Synthes (Johnson & Johnson) Recent Developments and Future Plans
2.8 Axogen
2.8.1 Axogen Details
2.8.2 Axogen Major Business
2.8.3 Axogen Bioengineered Skin Substitutes Product and Solutions
2.8.4 Axogen Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Axogen Recent Developments and Future Plans
2.9 Vericel Corporation
2.9.1 Vericel Corporation Details
2.9.2 Vericel Corporation Major Business
2.9.3 Vericel Corporation Bioengineered Skin Substitutes Product and Solutions
2.9.4 Vericel Corporation Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Vericel Corporation Recent Developments and Future Plans
2.10 LifeNet Health
2.10.1 LifeNet Health Details
2.10.2 LifeNet Health Major Business
2.10.3 LifeNet Health Bioengineered Skin Substitutes Product and Solutions
2.10.4 LifeNet Health Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 LifeNet Health Recent Developments and Future Plans
2.11 MTF Biologics
2.11.1 MTF Biologics Details
2.11.2 MTF Biologics Major Business
2.11.3 MTF Biologics Bioengineered Skin Substitutes Product and Solutions
2.11.4 MTF Biologics Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 MTF Biologics Recent Developments and Future Plans
2.12 Arthrex
2.12.1 Arthrex Details
2.12.2 Arthrex Major Business
2.12.3 Arthrex Bioengineered Skin Substitutes Product and Solutions
2.12.4 Arthrex Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Arthrex Recent Developments and Future Plans
2.13 Wright Medical Group NV (Stryker)
2.13.1 Wright Medical Group NV (Stryker) Details
2.13.2 Wright Medical Group NV (Stryker) Major Business
2.13.3 Wright Medical Group NV (Stryker) Bioengineered Skin Substitutes Product and Solutions
2.13.4 Wright Medical Group NV (Stryker) Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Wright Medical Group NV (Stryker) Recent Developments and Future Plans
2.14 Cook Biotech Incorporated
2.14.1 Cook Biotech Incorporated Details
2.14.2 Cook Biotech Incorporated Major Business
2.14.3 Cook Biotech Incorporated Bioengineered Skin Substitutes Product and Solutions
2.14.4 Cook Biotech Incorporated Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Cook Biotech Incorporated Recent Developments and Future Plans
2.15 Aroa Biosurgery
2.15.1 Aroa Biosurgery Details
2.15.2 Aroa Biosurgery Major Business
2.15.3 Aroa Biosurgery Bioengineered Skin Substitutes Product and Solutions
2.15.4 Aroa Biosurgery Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Aroa Biosurgery Recent Developments and Future Plans
2.16 Surgalign Holdings
2.16.1 Surgalign Holdings Details
2.16.2 Surgalign Holdings Major Business
2.16.3 Surgalign Holdings Bioengineered Skin Substitutes Product and Solutions
2.16.4 Surgalign Holdings Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Surgalign Holdings Recent Developments and Future Plans
2.17 Anika Therapeutics
2.17.1 Anika Therapeutics Details
2.17.2 Anika Therapeutics Major Business
2.17.3 Anika Therapeutics Bioengineered Skin Substitutes Product and Solutions
2.17.4 Anika Therapeutics Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Anika Therapeutics Recent Developments and Future Plans
2.18 Forticell Bioscience
2.18.1 Forticell Bioscience Details
2.18.2 Forticell Bioscience Major Business
2.18.3 Forticell Bioscience Bioengineered Skin Substitutes Product and Solutions
2.18.4 Forticell Bioscience Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Forticell Bioscience Recent Developments and Future Plans
2.19 MLM Biologics
2.19.1 MLM Biologics Details
2.19.2 MLM Biologics Major Business
2.19.3 MLM Biologics Bioengineered Skin Substitutes Product and Solutions
2.19.4 MLM Biologics Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 MLM Biologics Recent Developments and Future Plans
2.20 Promethean LifeSciences
2.20.1 Promethean LifeSciences Details
2.20.2 Promethean LifeSciences Major Business
2.20.3 Promethean LifeSciences Bioengineered Skin Substitutes Product and Solutions
2.20.4 Promethean LifeSciences Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 Promethean LifeSciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Bioengineered Skin Substitutes Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Bioengineered Skin Substitutes Players Market Share in 2021
3.2.2 Top 10 Bioengineered Skin Substitutes Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Bioengineered Skin Substitutes Players Head Office, Products and Services Provided
3.4 Bioengineered Skin Substitutes Mergers & Acquisitions
3.5 Bioengineered Skin Substitutes New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Bioengineered Skin Substitutes Revenue and Market Share by Type (2017-2022)
4.2 Global Bioengineered Skin Substitutes Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Bioengineered Skin Substitutes Revenue Market Share by Application (2017-2022)
5.2 Global Bioengineered Skin Substitutes Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Bioengineered Skin Substitutes Revenue by Type (2017-2028)
6.2 North America Bioengineered Skin Substitutes Revenue by Application (2017-2028)
6.3 North America Bioengineered Skin Substitutes Market Size by Country
6.3.1 North America Bioengineered Skin Substitutes Revenue by Country (2017-2028)
6.3.2 United States Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
6.3.3 Canada Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
6.3.4 Mexico Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Bioengineered Skin Substitutes Revenue by Type (2017-2028)
7.2 Europe Bioengineered Skin Substitutes Revenue by Application (2017-2028)
7.3 Europe Bioengineered Skin Substitutes Market Size by Country
7.3.1 Europe Bioengineered Skin Substitutes Revenue by Country (2017-2028)
7.3.2 Germany Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
7.3.3 France Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
7.3.5 Russia Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
7.3.6 Italy Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Bioengineered Skin Substitutes Revenue by Type (2017-2028)
8.2 Asia-Pacific Bioengineered Skin Substitutes Revenue by Application (2017-2028)
8.3 Asia-Pacific Bioengineered Skin Substitutes Market Size by Region
8.3.1 Asia-Pacific Bioengineered Skin Substitutes Revenue by Region (2017-2028)
8.3.2 China Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
8.3.3 Japan Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
8.3.4 South Korea Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
8.3.5 India Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
8.3.7 Australia Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Bioengineered Skin Substitutes Revenue by Type (2017-2028)
9.2 South America Bioengineered Skin Substitutes Revenue by Application (2017-2028)
9.3 South America Bioengineered Skin Substitutes Market Size by Country
9.3.1 South America Bioengineered Skin Substitutes Revenue by Country (2017-2028)
9.3.2 Brazil Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
9.3.3 Argentina Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Bioengineered Skin Substitutes Revenue by Type (2017-2028)
10.2 Middle East & Africa Bioengineered Skin Substitutes Revenue by Application (2017-2028)
10.3 Middle East & Africa Bioengineered Skin Substitutes Market Size by Country
10.3.1 Middle East & Africa Bioengineered Skin Substitutes Revenue by Country (2017-2028)
10.3.2 Turkey Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
10.3.4 UAE Bioengineered Skin Substitutes Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Bioengineered Skin Substitutes Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Bioengineered Skin Substitutes Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Bioengineered Skin Substitutes Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Bioengineered Skin Substitutes Revenue (USD Million) by Region (2017-2022)
Table 5. Global Bioengineered Skin Substitutes Revenue Market Share by Region (2023-2028)
Table 6. Allergan (AbbVie) Corporate Information, Head Office, and Major Competitors
Table 7. Allergan (AbbVie) Major Business
Table 8. Allergan (AbbVie) Bioengineered Skin Substitutes Product and Solutions
Table 9. Allergan (AbbVie) Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AlloSource Corporate Information, Head Office, and Major Competitors
Table 11. AlloSource Major Business
Table 12. AlloSource Bioengineered Skin Substitutes Product and Solutions
Table 13. AlloSource Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Organogenesis Corporate Information, Head Office, and Major Competitors
Table 15. Organogenesis Major Business
Table 16. Organogenesis Bioengineered Skin Substitutes Product and Solutions
Table 17. Organogenesis Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. BD Corporate Information, Head Office, and Major Competitors
Table 19. BD Major Business
Table 20. BD Bioengineered Skin Substitutes Product and Solutions
Table 21. BD Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Smith & Nephew Corporate Information, Head Office, and Major Competitors
Table 23. Smith & Nephew Major Business
Table 24. Smith & Nephew Bioengineered Skin Substitutes Product and Solutions
Table 25. Smith & Nephew Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Integra LifeSciences Corporate Information, Head Office, and Major Competitors
Table 27. Integra LifeSciences Major Business
Table 28. Integra LifeSciences Bioengineered Skin Substitutes Product and Solutions
Table 29. Integra LifeSciences Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Synthes (Johnson & Johnson) Corporate Information, Head Office, and Major Competitors
Table 31. Synthes (Johnson & Johnson) Major Business
Table 32. Synthes (Johnson & Johnson) Bioengineered Skin Substitutes Product and Solutions
Table 33. Synthes (Johnson & Johnson) Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Axogen Corporate Information, Head Office, and Major Competitors
Table 35. Axogen Major Business
Table 36. Axogen Bioengineered Skin Substitutes Product and Solutions
Table 37. Axogen Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Vericel Corporation Corporate Information, Head Office, and Major Competitors
Table 39. Vericel Corporation Major Business
Table 40. Vericel Corporation Bioengineered Skin Substitutes Product and Solutions
Table 41. Vericel Corporation Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. LifeNet Health Corporate Information, Head Office, and Major Competitors
Table 43. LifeNet Health Major Business
Table 44. LifeNet Health Bioengineered Skin Substitutes Product and Solutions
Table 45. LifeNet Health Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. MTF Biologics Corporate Information, Head Office, and Major Competitors
Table 47. MTF Biologics Major Business
Table 48. MTF Biologics Bioengineered Skin Substitutes Product and Solutions
Table 49. MTF Biologics Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Arthrex Corporate Information, Head Office, and Major Competitors
Table 51. Arthrex Major Business
Table 52. Arthrex Bioengineered Skin Substitutes Product and Solutions
Table 53. Arthrex Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Wright Medical Group NV (Stryker) Corporate Information, Head Office, and Major Competitors
Table 55. Wright Medical Group NV (Stryker) Major Business
Table 56. Wright Medical Group NV (Stryker) Bioengineered Skin Substitutes Product and Solutions
Table 57. Wright Medical Group NV (Stryker) Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Cook Biotech Incorporated Corporate Information, Head Office, and Major Competitors
Table 59. Cook Biotech Incorporated Major Business
Table 60. Cook Biotech Incorporated Bioengineered Skin Substitutes Product and Solutions
Table 61. Cook Biotech Incorporated Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Aroa Biosurgery Corporate Information, Head Office, and Major Competitors
Table 63. Aroa Biosurgery Major Business
Table 64. Aroa Biosurgery Bioengineered Skin Substitutes Product and Solutions
Table 65. Aroa Biosurgery Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Surgalign Holdings Corporate Information, Head Office, and Major Competitors
Table 67. Surgalign Holdings Major Business
Table 68. Surgalign Holdings Bioengineered Skin Substitutes Product and Solutions
Table 69. Surgalign Holdings Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Anika Therapeutics Corporate Information, Head Office, and Major Competitors
Table 71. Anika Therapeutics Major Business
Table 72. Anika Therapeutics Bioengineered Skin Substitutes Product and Solutions
Table 73. Anika Therapeutics Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Forticell Bioscience Corporate Information, Head Office, and Major Competitors
Table 75. Forticell Bioscience Major Business
Table 76. Forticell Bioscience Bioengineered Skin Substitutes Product and Solutions
Table 77. Forticell Bioscience Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. MLM Biologics Corporate Information, Head Office, and Major Competitors
Table 79. MLM Biologics Major Business
Table 80. MLM Biologics Bioengineered Skin Substitutes Product and Solutions
Table 81. MLM Biologics Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Promethean LifeSciences Corporate Information, Head Office, and Major Competitors
Table 83. Promethean LifeSciences Major Business
Table 84. Promethean LifeSciences Bioengineered Skin Substitutes Product and Solutions
Table 85. Promethean LifeSciences Bioengineered Skin Substitutes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Global Bioengineered Skin Substitutes Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 87. Global Bioengineered Skin Substitutes Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 88. Breakdown of Bioengineered Skin Substitutes by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Bioengineered Skin Substitutes Players Head Office, Products and Services Provided
Table 90. Bioengineered Skin Substitutes Mergers & Acquisitions in the Past Five Years
Table 91. Bioengineered Skin Substitutes New Entrants and Expansion Plans
Table 92. Global Bioengineered Skin Substitutes Revenue (USD Million) by Type (2017-2022)
Table 93. Global Bioengineered Skin Substitutes Revenue Share by Type (2017-2022)
Table 94. Global Bioengineered Skin Substitutes Revenue Forecast by Type (2023-2028)
Table 95. Global Bioengineered Skin Substitutes Revenue by Application (2017-2022)
Table 96. Global Bioengineered Skin Substitutes Revenue Forecast by Application (2023-2028)
Table 97. North America Bioengineered Skin Substitutes Revenue by Type (2017-2022) & (USD Million)
Table 98. North America Bioengineered Skin Substitutes Revenue by Type (2023-2028) & (USD Million)
Table 99. North America Bioengineered Skin Substitutes Revenue by Application (2017-2022) & (USD Million)
Table 100. North America Bioengineered Skin Substitutes Revenue by Application (2023-2028) & (USD Million)
Table 101. North America Bioengineered Skin Substitutes Revenue by Country (2017-2022) & (USD Million)
Table 102. North America Bioengineered Skin Substitutes Revenue by Country (2023-2028) & (USD Million)
Table 103. Europe Bioengineered Skin Substitutes Revenue by Type (2017-2022) & (USD Million)
Table 104. Europe Bioengineered Skin Substitutes Revenue by Type (2023-2028) & (USD Million)
Table 105. Europe Bioengineered Skin Substitutes Revenue by Application (2017-2022) & (USD Million)
Table 106. Europe Bioengineered Skin Substitutes Revenue by Application (2023-2028) & (USD Million)
Table 107. Europe Bioengineered Skin Substitutes Revenue by Country (2017-2022) & (USD Million)
Table 108. Europe Bioengineered Skin Substitutes Revenue by Country (2023-2028) & (USD Million)
Table 109. Asia-Pacific Bioengineered Skin Substitutes Revenue by Type (2017-2022) & (USD Million)
Table 110. Asia-Pacific Bioengineered Skin Substitutes Revenue by Type (2023-2028) & (USD Million)
Table 111. Asia-Pacific Bioengineered Skin Substitutes Revenue by Application (2017-2022) & (USD Million)
Table 112. Asia-Pacific Bioengineered Skin Substitutes Revenue by Application (2023-2028) & (USD Million)
Table 113. Asia-Pacific Bioengineered Skin Substitutes Revenue by Region (2017-2022) & (USD Million)
Table 114. Asia-Pacific Bioengineered Skin Substitutes Revenue by Region (2023-2028) & (USD Million)
Table 115. South America Bioengineered Skin Substitutes Revenue by Type (2017-2022) & (USD Million)
Table 116. South America Bioengineered Skin Substitutes Revenue by Type (2023-2028) & (USD Million)
Table 117. South America Bioengineered Skin Substitutes Revenue by Application (2017-2022) & (USD Million)
Table 118. South America Bioengineered Skin Substitutes Revenue by Application (2023-2028) & (USD Million)
Table 119. South America Bioengineered Skin Substitutes Revenue by Country (2017-2022) & (USD Million)
Table 120. South America Bioengineered Skin Substitutes Revenue by Country (2023-2028) & (USD Million)
Table 121. Middle East & Africa Bioengineered Skin Substitutes Revenue by Type (2017-2022) & (USD Million)
Table 122. Middle East & Africa Bioengineered Skin Substitutes Revenue by Type (2023-2028) & (USD Million)
Table 123. Middle East & Africa Bioengineered Skin Substitutes Revenue by Application (2017-2022) & (USD Million)
Table 124. Middle East & Africa Bioengineered Skin Substitutes Revenue by Application (2023-2028) & (USD Million)
Table 125. Middle East & Africa Bioengineered Skin Substitutes Revenue by Country (2017-2022) & (USD Million)
Table 126. Middle East & Africa Bioengineered Skin Substitutes Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Bioengineered Skin Substitutes Picture
Figure 2. Global Bioengineered Skin Substitutes Revenue Market Share by Type in 2021
Figure 3. Allogeneic Acellular
Figure 4. Xenogeneic
Figure 5. Allogeneic Cells
Figure 6. Autologous
Figure 7. Bioengineered Skin Substitutes Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Specialty Clinics Picture
Figure 10. Wound Care Centers Picture
Figure 11. Global Bioengineered Skin Substitutes Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Bioengineered Skin Substitutes Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Bioengineered Skin Substitutes Revenue Market Share by Region (2017-2028)
Figure 14. Global Bioengineered Skin Substitutes Revenue Market Share by Region in 2021
Figure 15. North America Bioengineered Skin Substitutes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Bioengineered Skin Substitutes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Bioengineered Skin Substitutes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Bioengineered Skin Substitutes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Bioengineered Skin Substitutes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Bioengineered Skin Substitutes Market Drivers
Figure 21. Bioengineered Skin Substitutes Market Restraints
Figure 22. Bioengineered Skin Substitutes Market Trends
Figure 23. Allergan (AbbVie) Recent Developments and Future Plans
Figure 24. AlloSource Recent Developments and Future Plans
Figure 25. Organogenesis Recent Developments and Future Plans
Figure 26. BD Recent Developments and Future Plans
Figure 27. Smith & Nephew Recent Developments and Future Plans
Figure 28. Integra LifeSciences Recent Developments and Future Plans
Figure 29. Synthes (Johnson & Johnson) Recent Developments and Future Plans
Figure 30. Axogen Recent Developments and Future Plans
Figure 31. Vericel Corporation Recent Developments and Future Plans
Figure 32. LifeNet Health Recent Developments and Future Plans
Figure 33. MTF Biologics Recent Developments and Future Plans
Figure 34. Arthrex Recent Developments and Future Plans
Figure 35. Wright Medical Group NV (Stryker) Recent Developments and Future Plans
Figure 36. Cook Biotech Incorporated Recent Developments and Future Plans
Figure 37. Aroa Biosurgery Recent Developments and Future Plans
Figure 38. Surgalign Holdings Recent Developments and Future Plans
Figure 39. Anika Therapeutics Recent Developments and Future Plans
Figure 40. Forticell Bioscience Recent Developments and Future Plans
Figure 41. MLM Biologics Recent Developments and Future Plans
Figure 42. Promethean LifeSciences Recent Developments and Future Plans
Figure 43. Global Bioengineered Skin Substitutes Revenue Share by Players in 2021
Figure 44. Bioengineered Skin Substitutes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 45. Global Top 3 Players Bioengineered Skin Substitutes Revenue Market Share in 2021
Figure 46. Global Top 10 Players Bioengineered Skin Substitutes Revenue Market Share in 2021
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 48. Global Bioengineered Skin Substitutes Revenue Share by Type in 2021
Figure 49. Global Bioengineered Skin Substitutes Market Share Forecast by Type (2023-2028)
Figure 50. Global Bioengineered Skin Substitutes Revenue Share by Application in 2021
Figure 51. Global Bioengineered Skin Substitutes Market Share Forecast by Application (2023-2028)
Figure 52. North America Bioengineered Skin Substitutes Sales Market Share by Type (2017-2028)
Figure 53. North America Bioengineered Skin Substitutes Sales Market Share by Application (2017-2028)
Figure 54. North America Bioengineered Skin Substitutes Revenue Market Share by Country (2017-2028)
Figure 55. United States Bioengineered Skin Substitutes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Canada Bioengineered Skin Substitutes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Mexico Bioengineered Skin Substitutes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Europe Bioengineered Skin Substitutes Sales Market Share by Type (2017-2028)
Figure 59. Europe Bioengineered Skin Substitutes Sales Market Share by Application (2017-2028)
Figure 60. Europe Bioengineered Skin Substitutes Revenue Market Share by Country (2017-2028)
Figure 61. Germany Bioengineered Skin Substitutes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. France Bioengineered Skin Substitutes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. United Kingdom Bioengineered Skin Substitutes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Russia Bioengineered Skin Substitutes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Italy Bioengineered Skin Substitutes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Asia-Pacific Bioengineered Skin Substitutes Sales Market Share by Type (2017-2028)
Figure 67. Asia-Pacific Bioengineered Skin Substitutes Sales Market Share by Application (2017-2028)
Figure 68. Asia-Pacific Bioengineered Skin Substitutes Revenue Market Share by Region (2017-2028)
Figure 69. China Bioengineered Skin Substitutes Revenue and Growth Rate (2
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs